Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Cerezyme Prescribers

Articles with lock require a subscription to GLG News | Request a free trial
November 24, 2008
This strategy is running out of steam.
Analysis of: How a Drug Maker Tries to Outwit Generics | online.wsj.com
Author: GLG Expert Contributor
These strategies are running out of steam as insurers, and even the general public, are catching on.  Most insurers will only pay for generic modafanil, and these new versions will not sell as much as they would have even 5 years ago.  The abuse potential of the drug may help, as brand-name...
August 28, 2008
Dangers of Methadone Usage
Analysis of: Dr. Mark Yergin testifies to Congress | www.nytimes.com
Author: William Fink, President, Managed Care Pharmacy Consultants, Inc
Doctors must be educated on the correct use of Methadone if unnecessary deaths are to be avoided.
August 21, 2008
Minimal Impact on Stent Market
Analysis of: Heart Stents No Better Than Drugs for Chest Pain Over Time | www.bloomberg.com
Author: GLG Expert Contributor
Because equivalent results were shown, there will be no change in stent placement volumes.
July 21, 2008
Healthcare industry NOT immune to economic illness
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor
The idea that people will always buy prescription and OTC drugs and will go to the physician and dentist, no matter what the economic conditions in the country, is, in my opinion, erroneous.  People's first priorities are getting to work (requiring gas), food, and shelter.  The most money...
July 3, 2008
Yes - please stop the cycle of 70 deaths then pull the drug!
Analysis of: Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline | online.wsj.com
Author: GLG Expert Contributor
Drugs are released to the market without adequate study, then, after around 70 to 100 patient deaths due to the drug are reported, the drug is pulled from the market.  Getting in front of this "problem" would improve the safety of our drug supply.
June 30, 2008
Looks like the Britons don't care anyway...
Analysis of: Roche decision denies cancer drug to Britons | www.ft.com
Author: GLG Expert Contributor
Drug company (Roche) retaliates against an agency that speaks the truth about their chemical - that it's cost is not worth the minimal benefit.  This will become more common as time goes on, even here in the bastion of capitalism.
June 26, 2008
Trends for Chronic Kidney Disease (CKD)
Analysis of: Resource Article: “Chronic Kidney Disease Prevalence Increases, Awareness Remains Low,” Drug Benefit Trends (vol. 20, no. 5, May 2008) | jama.ama-assn.org
Author: William Fink, President, Managed Care Pharmacy Consultants, Inc
There will be an increased use of costly diaylsis, especially among those people 70 years or older.  One would think that there would be a greater awareness of a disease consting $31 billion dollars a year.  However, this does not seem to be the case.
June 25, 2008
Best acne care product I've seen.
Analysis of: What Skin Care Routines and Treatments Are Effective for Adolescent Acne? | www.medscape.com
Author: GLG Expert Contributor
Keep the stuff refrigerated.
June 25, 2008
Antipsychotics are not just "overused" - they increase mortality and morbidity.
Analysis of: Doctors Say Medication Is Overused in Dementia | www.nytimes.com
Author: GLG Expert Contributor
Antipsychotic drugs have been shown to increase morbidity and mortality in demented patients.  These agents are used to keep patients calm and easy to manipulate because there is not enough nursing home staff to adequately care for patients mental and physical needs.  "Chemical straight-jackets",...
June 24, 2008
Choose your patient wisely.
Analysis of: New Study Probes Safety of Erythropoiesis-Stimulating Agents | www.medscape.com
Author: GLG Expert Contributor
For the right patient, epoietin products can make a world of difference in quality of life.  For the wrong patient, the drugs can cause clotting and can be fatal.  (I was involved with a patient's care once who died from a PE due to epoietin.  She had a hematocrit of 55% when she died.) ...

Page : 1 2 Next1 to 10 of 15

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747